A bacterial cellulose-polyurethane composite material, preparation method, and use are described. The preparation method comprises: performing organic solvent exchange on bacterial cellulose microfibers, and obtaining bacterial cellulose microfiber composite substance A and composite substance B of different concentrations; under oil bath conditions, adding a polymer polyol and a diisocyanate compound and performing an addition polymerization reaction, obtaining, via the reaction, a bacterial cellulose composite polyurethane foam prepolymer; and subsequently performing curing and obtaining the bacterial cellulose-polyurethane composite material. By combining bacterial cellulose microfibers and polyurethane foam material, the mechanical properties of the composite material are significantly improved; the large amount of hydroxyl groups on the surfaces of the bacterial cellulose nanofibers effectively strengthens the hydrophilicity and water absorption capability of the composite material; and the favorable tissue affinity of bacterial cellulose can also improve the biocompatibility of polyurethane material.

A bacterial cellulose-polyurethane composite material, preparation method, and use are described. The preparation method comprises: performing organic solvent exchange on bacterial cellulose microfibers, and obtaining bacterial cellulose microfiber composite substance A and composite substance B of different concentrations; under oil bath conditions, adding a polymer polyol and a diisocyanate compound and performing an addition polymerization reaction, obtaining, via the reaction, a bacterial cellulose composite polyurethane foam prepolymer; and subsequently performing curing and obtaining the bacterial cellulose-polyurethane composite material. By combining bacterial cellulose microfibers and polyurethane foam material, the mechanical properties of the composite material are significantly improved; the large amount of hydroxyl groups on the surfaces of the bacterial cellulose nanofibers effectively strengthens the hydrophilicity and water absorption capability of the composite material; and the favorable tissue affinity of bacterial cellulose can also improve the biocompatibility of polyurethane material.

A polypeptide monolayer with a high surface potential and hydrophobicity, and a preparation method and application thereof. The polypeptide is composed of polypeptide molecules with a molecular weight of (1.48±0.2)×10.sup.5 g/mol, a thickness of the monolayer is 17.3-18.5 nm, the exposure of primary amino groups on the surface of the monolayer is 11-11.8%, a Zeta potential of the polypeptide monolayer is (-3)-(-2) mV, and a contact angle of the monolayer is 84±1°. A micro-nano structure on the surface of the polypeptide monolayer allows the polypeptide monolayer to have certain hydrophobicity, which is beneficial to water proofing of the surface of biomimetic skin. Furthermore, the surface of the polypeptide monolayer has a relatively high potential, which can improve biocompatibility, hemocompatibility, and cell adhesion, proliferation, and differentiation abilities.

A polypeptide monolayer with a high surface potential and hydrophobicity, and a preparation method and application thereof. The polypeptide is composed of polypeptide molecules with a molecular weight of (1.48±0.2)×10.sup.5 g/mol, a thickness of the monolayer is 17.3-18.5 nm, the exposure of primary amino groups on the surface of the monolayer is 11-11.8%, a Zeta potential of the polypeptide monolayer is (-3)-(-2) mV, and a contact angle of the monolayer is 84±1°. A micro-nano structure on the surface of the polypeptide monolayer allows the polypeptide monolayer to have certain hydrophobicity, which is beneficial to water proofing of the surface of biomimetic skin. Furthermore, the surface of the polypeptide monolayer has a relatively high potential, which can improve biocompatibility, hemocompatibility, and cell adhesion, proliferation, and differentiation abilities.

A method for use of a double-structured tissue implant or a secondary scaffold stand-alone implant for treatment of tissue defects. The double-structured tissue implant comprising a primary scaffold and a secondary scaffold consisting of a soluble collagen solution in combination with a non-ionic surfactant generated and positioned within the primary scaffold. A method of use of a stand-alone secondary scaffold implant or unit for treatment of tissue defects.

A method for use of a double-structured tissue implant or a secondary scaffold stand-alone implant for treatment of tissue defects. The double-structured tissue implant comprising a primary scaffold and a secondary scaffold consisting of a soluble collagen solution in combination with a non-ionic surfactant generated and positioned within the primary scaffold. A method of use of a stand-alone secondary scaffold implant or unit for treatment of tissue defects.

A method for use of a double-structured tissue implant or a secondary scaffold stand-alone implant for treatment of tissue defects. The double-structured tissue implant comprising a primary scaffold and a secondary scaffold consisting of a soluble collagen solution in combination with a non-ionic surfactant generated and positioned within the primary scaffold. A method of use of a stand-alone secondary scaffold implant or unit for treatment of tissue defects.

Compositions-of-matter comprising a matrix made of one or more, preferably two or more elastic layers and one or more viscoelastic layer are disclosed. The compositions-of-matter are characterized by high water-impermeability and optionally by self-recovery. Processes of preparing the compositions-of-matter and uses thereof as tissue substitutes or for repairing damaged tissues are also disclosed.

Compositions-of-matter comprising a matrix made of one or more, preferably two or more elastic layers and one or more viscoelastic layer are disclosed. The compositions-of-matter are characterized by high water-impermeability and optionally by self-recovery. Processes of preparing the compositions-of-matter and uses thereof as tissue substitutes or for repairing damaged tissues are also disclosed.

The present disclosure provides tissue products produced from extracellular tissue matrices. The tissue products can include acellular extracellular matrices including combinations of different tissue types. The combination can harness various properties of the different tissues to provide improved composite structures with desired mechanical and/or biologic properties.